{"id":"W1926565992","doi":"10.3978/j.issn.2078-6891.2014.019","title":"Outcomes of patients treated with capecitabine and temozolamide for advanced pancreatic neuroendocrine tumors (PNETs) and non-PNETs.","year":2014,"lang":"en","type":"article","venue":"PubMed","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Capecitabine; Neuroendocrine tumors; Internal medicine; Hazard ratio; Gastroenterology; Chemotherapy; Cohort; Retrospective cohort study; Pancreas; Progression-free survival; Cancer; Rectum; Oncology; Colorectal cancer; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000913151,0.0002767223,0.0007207228,0.0002005451,0.00005692496,0.00001728113,0.00009214563,0.000005992561,0.000005243829],"category_scores_gemma":[0.0009826348,0.0001941315,0.00004928499,0.0001982784,0.0002036739,0.0001701792,0.00007439072,0.0001280214,7.877809e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002627249,"about_ca_system_score_gemma":0.00001640416,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005332011,"about_ca_topic_score_gemma":0.00003671543,"domain_scores_codex":[0.9981307,0.00004577996,0.0003746923,0.0004583377,0.0003493555,0.0006411708],"domain_scores_gemma":[0.9986444,0.0003122132,0.0001631016,0.0003393489,0.0001878957,0.0003531113],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001380252,0.0001813233,0.9606006,0.0004306951,0.00007260218,0.0000828605,0.0000110463,0.000003939468,0.000338586,0.00002625387,0.00006505925,0.03680681],"study_design_scores_gemma":[0.00991402,0.00137618,0.980707,0.00003727736,0.0001211899,0.0001179175,0.00002174241,0.0001471945,0.005900364,0.00004468922,0.001448067,0.0001642889],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955033,0.0001022166,0.00002926491,0.0006481922,0.00003051275,0.003171083,0.0000367458,0.00005409633,0.0004245917],"genre_scores_gemma":[0.9966502,0.00009019449,0.0006661637,0.0002063812,0.00002202883,0.001243108,0.00003903886,0.00005797429,0.001024923],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03664253,"threshold_uncertainty_score":0.7916451,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009728381181289315,"score_gpt":0.2446690522949328,"score_spread":0.2349406711136435,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}